| MolName | (5Z)-3-benzyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C23H20N4O2S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCCC3)N=C(C=CC=C3)N3C2=O)N(Cc2ccccc2)C1=S |
| InChI | InChI=1S/C23H20N4O2S2/c28-21-17(20(25-11-6-7-12-25)24-19-10-4-5-13-26(19)21)14-18-22(29)27(23(30)31-18)15-16-8-2-1-3-9-16/h1-5,8-10,13-14H,6-7,11-12,15H2 |
| InChIK | GXDYGSLVXQIYTB-UHFFFAOYSA-N |
| TotalMolweight | 448.57 |
| Molweight | 448.57 |
| MonoisotopicMass | 448.102766 |
| CLogP | 1.7404 |
| CLogS | -5.099 |
| H Acceptors | 6 |
| TotalSurfaceArea | 328.26 |
| Relative PSA | 0.28554 |
| PolarSurfaceArea | 113.61 |
| Druglikeness | 5.3368 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.48387 |
| Fragments | 1 |
| Non HAtoms | 31 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 4 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 7 |
| Symmetricatoms | 4 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-3-benzyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-benzyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one